Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

News und Analysen

Trane Technologies to Present at the Barclays Industrial Select Conference: https://brand.tranetechnologies.com/content/dam/cs-corporate/brand-center/logo-black.png
Trane Technologies to Present at the Barclays Industrial Select Conference


Trane Technologies plc (NYSE: TT) a global climate innovator, announced today that company leadership will participate in a fireside chat at the Barclays Industrial Select Conference. They will

NICE Provides Dial-in Details for its Fourth Quarter 2021 Results Teleconference: https://mms.businesswire.com/media/20191203005409/en/615391/5/NICE_inContact.jpg
NICE Provides Dial-in Details for its Fourth Quarter 2021 Results Teleconference


NICE (Nasdaq: NICE) will announce its fourth quarter 2021 results on Thursday, February 17th, before the opening of the NASDAQ Stock Exchange
Later that day, management will host a conference call

Trane Technologies to Present at Citi’s 2022 Global Industrial Tech and Mobility Conference: https://brand.tranetechnologies.com/content/dam/cs-corporate/brand-center/logo-black.png
Trane Technologies to Present at Citi’s 2022 Global Industrial Tech and Mobility Conference


Trane Technologies plc (NYSE: TT), a global climate innovator, announced today that company leadership will participate in a fireside chat at Citi’s 2022 Global Industrial Tech and Mobility

DGAP-News: Linde plc: Linde Reports Full-Year and Fourth-Quarter 2021 Results (Earnings Release Tables Attached) : http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23621/TheLindeGroup-Logo.svg.png
DGAP-News: Linde plc: Linde Reports Full-Year and Fourth-Quarter 2021 Results (Earnings Release Tables Attached)
DGAP-News: Linde plc: Linde Reports Full-Year and Fourth-Quarter 2021 Results (Earnings Release Tables Attached)
Transgene Appoints Steven Bloom as Chief Business Officer: https://mms.businesswire.com/media/20191209005543/en/255636/5/logo_TRANSGENE.jpg
Transgene Appoints Steven Bloom as Chief Business Officer


Regulatory News:



Transgene (Euronext Paris: TNG) (Paris:TNG), a biotech company that designs and develops virus-based immunotherapeutics against cancer, announced today that it has appointed

Pernod Ricard: Record breaking H1 FY22 Sales and PRO1 at c. €6bn and c. €2bn: https://mms.businesswire.com/media/20200212005993/en/773259/5/Createurs_de_Convivialite.jpg
Pernod Ricard: Record breaking H1 FY22 Sales and PRO1 at c. €6bn and c. €2bn


Regulatory News:



Pernod Ricard (Paris:RI):



Press release - Paris, 10 February 2022



SALES



Sales for H1 FY22 totalled €5,959m, with an organic growth of +17% (+20% reported), with a

Pernod Ricard: Record breaking H1 FY22 Sales and PRO1 at c. €6bn and c. €2bn: https://mms.businesswire.com/media/20200212005993/en/773259/5/Createurs_de_Convivialite.jpg
Pernod Ricard: Record breaking H1 FY22 Sales and PRO1 at c. €6bn and c. €2bn


Regulatory News:



Pernod Ricard (Paris:RI):



Press release - Paris, 10 February 2022



SALES



Sales for H1 FY22 totalled €5,959m, with an organic growth of +17% (+20% reported), with a

DGAP-News: Delivery Hero exceeds 2021 GMV guidance and sets 2022 outlook to reach positive adjusted EBITDA for its platform business: https://www.deliveryhero.com/newsroom/downloads/
DGAP-News: Delivery Hero exceeds 2021 GMV guidance and sets 2022 outlook to reach positive adjusted EBITDA for its platform business
DGAP-News: Delivery Hero exceeds 2021 GMV guidance and sets 2022 outlook to reach positive adjusted EBITDA for its platform business
DGAP-News: Delivery Hero übertrifft GMV-Prognose für 2021 und erwartet für 2022 ein positives bereinigtes EBITDA des Plattformgeschäfts: https://www.deliveryhero.com/newsroom/downloads/
DGAP-News: Delivery Hero übertrifft GMV-Prognose für 2021 und erwartet für 2022 ein positives bereinigtes EBITDA des Plattformgeschäfts
DGAP-News: Delivery Hero übertrifft GMV-Prognose für 2021 und erwartet für 2022 ein positives bereinigtes EBITDA des Plattformgeschäfts
DGAP-News: Bechtle zeigt auch 2021 eine starke Entwicklung: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24050/225px-Bechtle_AG_20xx_logo.svg.png
DGAP-News: Bechtle zeigt auch 2021 eine starke Entwicklung
DGAP-News: Bechtle zeigt auch 2021 eine starke Entwicklung
DGAP-News: Bechtle zeigt auch 2021 eine starke Entwicklung: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24050/225px-Bechtle_AG_20xx_logo.svg.png
DGAP-News: Bechtle zeigt auch 2021 eine starke Entwicklung
DGAP-News: Bechtle zeigt auch 2021 eine starke Entwicklung
DGAP-News: Bechtle again reports strong performance in 2021: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24050/225px-Bechtle_AG_20xx_logo.svg.png
DGAP-News: Bechtle again reports strong performance in 2021
DGAP-News: Bechtle again reports strong performance in 2021
DGAP-News: Bechtle again reports strong performance in 2021: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24050/225px-Bechtle_AG_20xx_logo.svg.png
DGAP-News: Bechtle again reports strong performance in 2021
DGAP-News: Bechtle again reports strong performance in 2021
Gap Inc. to Report Fourth Quarter 2021 Results on March 3: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24465/225px-Gap_logo.svg.png
Gap Inc. to Report Fourth Quarter 2021 Results on March 3


Gap Inc. (NYSE: GPS) will report its fourth quarter 2021 earnings results by press release on March 3, 2022 at 1:15 p.m. Pacific Time.



In addition, the company will host a summary of Gap Inc.’s

Nanobiotix Announces Publication of New Clinical Case Study Highlighting First Patient Experience of NBTXR3 Treatment for Pancreatic Cancer: https://mms.businesswire.com/media/20191111005579/en/744572/5/LOGO_NANO_EXPANDING_LIFE.jpg
Nanobiotix Announces Publication of New Clinical Case Study Highlighting First Patient Experience of NBTXR3 Treatment for Pancreatic Cancer


Regulatory News:



NANOBIOTIX (Euronext: NANO – NASDAQ: NBTX – the ‘‘Company’’), a late-stage clinical biotechnology company pioneering physics-based approaches to expand treatment possibilities

IFF Reports Fourth Quarter and Full Year 2021 Results: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24521/International_Flavors_and_Fragrances_%28logo%29.png
IFF Reports Fourth Quarter and Full Year 2021 Results


International Flavors & Fragrances Inc. (NYSE: IFF) reported financial results for the fourth quarter and full year ended December 31, 2021.



Fourth Quarter 2021 Consolidated Summary:


Reporte

Intevac Announces Fourth Quarter and Full Year 2021 Financial Results: https://mms.businesswire.com/media/20191101005110/en/497226/5/IVAC_LOGO_Horizontal_.jpg
Intevac Announces Fourth Quarter and Full Year 2021 Financial Results


Intevac, Inc. (Nasdaq: IVAC) today reported financial results for the fiscal fourth quarter and year ended January 1, 2022.



Fiscal 2021 Highlights




  • Completion of the sale of our Photonics

IFF Appoints Barry A. Bruno to Board of Directors: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24521/International_Flavors_and_Fragrances_%28logo%29.png
IFF Appoints Barry A. Bruno to Board of Directors


IFF (NYSE: IFF) today announced the appointment of Barry A. Bruno to the Company’s Board of Directors as an independent director, effective February 8, 2022.



“We are pleased to welcome Barry to

Diodes Incorporated Reports Record Fourth Quarter and Fiscal 2021 Financial Results: https://mms.businesswire.com/media/20200323005671/en/218867/5/Diodes_logo_%28r%29_small.jpg
Diodes Incorporated Reports Record Fourth Quarter and Fiscal 2021 Financial Results


Diodes Incorporated (DIODES™) (Nasdaq: DIOD) today reported its financial results for the fourth quarter and fiscal year ended December 31, 2021.



Fourth Quarter and Recent Highlights




  • Revenue

LiveRamp Announces Strong Third Quarter Results and Raises Full Year Outlook: https://mms.businesswire.com/media/20191105005799/en/754502/5/Source-Logo-300.jpg
LiveRamp Announces Strong Third Quarter Results and Raises Full Year Outlook


LiveRamp® (NYSE: RAMP), the leading global data connectivity platform, today announced its financial results for the quarter ended December 31, 2021.


This press release features multimedia. View

Blue Bird Reports Fiscal 2022 First Quarter Results;
Focused on Margin Expansion and EV Growth;
Impacted by Supply Chain Disruptions, Inflationary Pressures;
Confirms FY2022 Guidance: https://mms.businesswire.com/media/20210323005889/en/866918/5/Nuvve+%281%29+%28002%29.jpg
Blue Bird Reports Fiscal 2022 First Quarter Results; Focused on Margin Expansion and EV Growth; Impacted by Supply Chain Disruptions, Inflationary Pressures; Confirms FY2022 Guidance


Blue Bird Corporation (“Blue Bird”) (Nasdaq: BLBD), the leader in electric and low-emission school buses, announced today its fiscal 2022 first quarter results. GAAP net loss for the quarter of

Samsung Galaxy S22 Lineup Lands at T-Mobile and Sprint … and You Can Get it FREE: https://mms.businesswire.com/media/20191206005014/en/398400/5/30686-44937-TMO_Magenta_12.13.jpg
Samsung Galaxy S22 Lineup Lands at T-Mobile and Sprint … and You Can Get it FREE


2022 is the year of no compromises. Today, T-Mobile (NASDAQ: TMUS) announced the Samsung Galaxy S22, Galaxy S22+, Galaxy S22 Ultra and Galaxy Tab S8+ 5G are all coming to the Un-carrier. New and

Samsung Galaxy S22 Lineup Lands at T-Mobile and Sprint … and You Can Get it FREE: https://mms.businesswire.com/media/20191206005014/en/398400/5/30686-44937-TMO_Magenta_12.13.jpg
Samsung Galaxy S22 Lineup Lands at T-Mobile and Sprint … and You Can Get it FREE


2022 is the year of no compromises. Today, T-Mobile (NASDAQ: TMUS) announced the Samsung Galaxy S22, Galaxy S22+, Galaxy S22 Ultra and Galaxy Tab S8+ 5G are all coming to the Un-carrier. New and

Samsung Galaxy S22 Lineup Lands at T-Mobile and Sprint … and You Can Get it FREE: https://mms.businesswire.com/media/20191206005014/en/398400/5/30686-44937-TMO_Magenta_12.13.jpg
Samsung Galaxy S22 Lineup Lands at T-Mobile and Sprint … and You Can Get it FREE


2022 is the year of no compromises. Today, T-Mobile (NASDAQ: TMUS) announced the Samsung Galaxy S22, Galaxy S22+, Galaxy S22 Ultra and Galaxy Tab S8+ 5G are all coming to the Un-carrier. New and

Eurofins to Acquire Genetic Testing Service JSC and Enter the Clinical Genetic Testing Market in Vietnam: https://mms.businesswire.com/media/20200421005718/en/318625/5/EUROFINS_jpg.jpg
Eurofins to Acquire Genetic Testing Service JSC and Enter the Clinical Genetic Testing Market in Vietnam


Eurofins Scientific (“Eurofins”) (Paris:ERF), a global scientific leader in bioanalytical testing and clinical diagnostics testing, announces that its subsidiary, Eurofins Clinical Testing Lux